{"id":"W2807973130","doi":"10.1016/s2352-3018(18)30099-7","title":"What did we learn from the bictegravir switch studies?","year":2018,"lang":"en","type":"letter","venue":"The Lancet HIV","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"AIDS Vancouver","funders":"","keywords":"Tenofovir alafenamide; Emtricitabine; Dolutegravir; Medicine; Abacavir; Internal medicine; Virology; Oncology; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003698062,0.0005047187,0.001061669,0.0000510178,0.0003043209,0.0001413632,0.0006283781,0.0003331345,0.0006194274],"category_scores_gemma":[0.00007648109,0.0002117384,0.0002178909,0.0001667414,0.0003228601,0.00008857872,0.0002279727,0.001618048,0.005559635],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001585041,"about_ca_system_score_gemma":0.0001171443,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002942876,"about_ca_topic_score_gemma":0.00004952069,"domain_scores_codex":[0.9977154,0.000205069,0.0003331102,0.0005107286,0.0006256577,0.0006100773],"domain_scores_gemma":[0.9974304,0.0007582703,0.0001999952,0.001444583,0.0001163915,0.0000503894],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007647896,0.00002607179,0.001353115,0.00005511462,0.001577603,0.0002944104,0.00456953,5.254407e-8,0.000008607495,0.00001320041,0.9894133,0.002612506],"study_design_scores_gemma":[0.001303026,0.00004731639,0.0008396585,0.001067473,0.0007451093,0.00002317102,0.001016323,0.000003454633,0.00007876971,0.001145672,0.993476,0.000254052],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.003774363,0.01495816,0.000004668111,0.9754061,0.00171926,0.000727899,0.00007821788,0.0001405743,0.003190781],"genre_scores_gemma":[0.000410319,0.02344815,0.000271428,0.6167873,0.03161634,0.0001671108,0.001003015,0.0001025434,0.3261938],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.3586188,"threshold_uncertainty_score":0.9952146,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07294376727259798,"score_gpt":0.3181492163741765,"score_spread":0.2452054491015785,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}